Cargando…
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
Randomized controlled trials (RCTs) show that decreases in low-density lipoprotein cholesterol (LDL-C) by the use of statins cause a significant reduction in the development of cardiovascular disease (CVD). However, one of our previous studies showed that, among eight RCTs that investigated the effe...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657259/ https://www.ncbi.nlm.nih.gov/pubmed/36362288 http://dx.doi.org/10.3390/ijms232113499 |